[
  {
    "date": "2023-12-30",
    "symbol": "TRVI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "TREVI THERAPEUTICS, INC.",
    "entitycentralindexkey": 1563880,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "TRVI",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38886",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "45-0834299",
    "entityaddressaddressline1": "195 Church Street",
    "entityaddressaddressline2": "16th Floor",
    "entityaddresscityortown": "New Haven",
    "entityaddressstateorprovince": "CT",
    "entityaddresspostalzipcode": 6510,
    "cityareacode": 203,
    "localphonenumber": "304-2499",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Hartford, Connecticut",
    "cashandcashequivalentsatcarryingvalue": 32397000,
    "marketablesecuritiescurrent": 50574000,
    "prepaidexpensecurrent": 3621000,
    "otherassetscurrent": 955000,
    "assetscurrent": 87547000,
    "operatingleaserightofuseasset": 1137000,
    "otherassetsnoncurrent": 297000,
    "propertyplantandequipmentnet": 216000,
    "financeleaserightofuseasset": 206000,
    "assets": 89403000,
    "accountspayablecurrent": 1809000,
    "accruedliabilitiescurrent": 3709000,
    "operatingleaseliabilitycurrent": 184000,
    "financeleaseliabilitycurrent": 122000,
    "liabilitiescurrent": 5824000,
    "operatingleaseliabilitynoncurrent": 1001000,
    "financeleaseliabilitynoncurrent": 31000,
    "liabilities": 6856000,
    "commonstockvalue": 68000,
    "additionalpaidincapital": 321642000,
    "accumulatedothercomprehensiveincomelossnetoftax": -29000,
    "retainedearningsaccumulateddeficit": -239134000,
    "stockholdersequity": 82547000,
    "liabilitiesandstockholdersequity": 89403000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 68283699,
    "commonstocksharesoutstanding": 68283699,
    "researchanddevelopmentexpense": 23683000,
    "generalandadministrativeexpense": 10240000,
    "operatingexpenses": 33923000,
    "operatingincomeloss": -33923000,
    "interestincomeexpensenonoperatingnet": 4748000,
    "othernonoperatingincomeexpense": 469000,
    "interestexpense": 391000,
    "nonoperatingincomeexpense": 4826000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -29097000,
    "incometaxexpensebenefit": -32000,
    "netincomeloss": -29065000,
    "earningspersharebasic": -0.29,
    "earningspersharediluted": -0.29,
    "weightedaveragenumberofsharesoutstandingbasic": 99033373,
    "weightedaveragenumberofdilutedsharesoutstanding": 99033373,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 93000,
    "comprehensiveincomenetoftax": -28972000,
    "sharesoutstanding": 68283699,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2247000,
    "stockissuedduringperiodvaluestockoptionsexercised": 74000,
    "stockissuedduringperiodsharesstockoptionsexercised": 146081,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 68000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 50091,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 750000,
    "stockissuedduringperiodvaluestockprefundedwarrantexercise": 7000,
    "stockissuedduringperiodsharestockprefundedwarrantexercise": 7394097,
    "sharebasedcompensation": 2247000,
    "writeoffofdeferredofferingcosts": 390000,
    "operatingleaserightofuseassetamortizationexpense": 377000,
    "amortizationoffinancingcostsanddiscounts": 180000,
    "depreciationdepletionandamortization": 123000,
    "gainlossondispositionofassets1": -10000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 2125000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2850000,
    "increasedecreaseinaccountspayable": -1049000,
    "increasedecreaseinaccruedliabilities": 52000,
    "netcashprovidedbyusedinoperatingactivities": -31710000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 69497000,
    "paymentstoacquiremarketablesecurities": 9932000,
    "paymentstoacquirepropertyplantandequipment": 137000,
    "netcashprovidedbyusedininvestingactivities": 59428000,
    "proceedsfromatmarketsalesnetofcommissions": 1710000,
    "proceedsfromstockoptionsexercised": 74000,
    "proceedsfromstockplans": 68000,
    "repaymentsoftermloantermloanfinalfeeandprepaymentpremium": 9409000,
    "paymentsofstockissuancecosts": 258000,
    "financeleaseprincipalpayments": 95000,
    "netcashprovidedbyusedinfinancingactivities": -7910000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 19808000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 32397000,
    "interestpaidnet": 331000,
    "incometaxcreditsexchangedforcash": 55000,
    "cashcashequivalentsandmarketablesecurities": 83000000,
    "propertyplantandequipmentusefullife": "P3Y",
    "numberofreportablesegments": 1,
    "numberofoperatingsegments": 1,
    "availableforsaledebtsecuritiesamortizedcostbasis": 45686000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 20000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 53000,
    "availableforsalesecuritiesdebtsecurities": 45653000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearamortizedcost": 49651000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsamortizedcost": 952000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 49618000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsfairvalue": 956000,
    "cashandcashequivalentsfairvaluedisclosure": 30404000,
    "investmentsfairvaluedisclosure": 45653000,
    "assetsfairvaluedisclosure": 30404000,
    "firstyearofpaymentssquarefeetofoccupiedspace": 10500,
    "secondyearofpaymentssquarefeetofoccupiedspace": 11500,
    "remainingleasepaymentssquarefeetofoccupiedspace": 12500,
    "operatingandfinanceleaserightofuseasset": 1343000,
    "operatingandfinanceleaseliability": 1338000,
    "operatingleasecost": 287000,
    "financeleaserightofuseassetamortizationandinterestexpense": 36000,
    "leasecost": 323000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 303000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 349000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 368000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 377000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 95000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1492000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 307000,
    "operatingleaseliability": 1185000,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 126000,
    "financeleaseliabilitypaymentsdueyeartwo": 32000,
    "financeleaseliabilitypaymentsdue": 158000,
    "financeleaseliabilityundiscountedexcessamount": 5000,
    "financeleaseliability": 153000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y3M18D",
    "financeleaseweightedaverageremainingleaseterm1": "P1Y3M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.11,
    "financeleaseweightedaveragediscountratepercent": 0.0437,
    "operatingleasepayments": 231000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1289000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 242000,
    "propertyplantandequipmentgross": 263000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 134000,
    "depreciation": 81000,
    "accruedemployeebenefitscurrent": 1614000,
    "accruedresearchanddevelopmentliabilities": 1579000,
    "accruedconsultingandprofessionalfees": 510000,
    "otheraccruedliabilitiescurrent": 6000,
    "debtinstrumentmaturitydate": "2024-02-01",
    "debtinstrumentfeeamount": 1200000,
    "deferredfinancecostsnet": 21000,
    "accrualoffinalpaymentfee": 150000,
    "contingentinterestrateincrease": 0.02,
    "interestexpensedebtexcludingamortization": 202000,
    "amortizationoffinancingcosts": 30000,
    "maximumaggregateofferingpriceofcommonstockwhichmayissueandsaleunderagreement": 62000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4746508,
    "commonstockcapitalsharesreservedforfutureissuance": 40931506,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 31227802,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": 7399201,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P4Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 7114975,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1802675,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoutstandingnumberofsharestilldate": 1157894,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Options granted under the 2019 Plan and the 2012 Plan have a maximum term of ten years. Options granted to employees, officers and non-employees generally vest over four years based on varying vesting schedules that primarily include: 25% vesting on the first anniversary date of grant and the balance ratably over the next 36 months or vesting in equal monthly or quarterly installments over four years.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4746508,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 173000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 3800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 318075,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 237327,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2805959,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 2506341,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 1.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 3.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 2.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedweightedaveragecontractualterm": "P8Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 685000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 273000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedaggregateintrinsicvalue": 412000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.034,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.048,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.471,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "currentstateandlocaltaxexpensebenefit": -32000,
    "currentfederalstateandlocaltaxexpensebenefit": -32000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.058,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.029,
    "effectiveincometaxratereconciliationrefundabletaxcredit": 0.001,
    "effectiveincometaxratereconciliationpermanentadjustments": -0.006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.291,
    "effectiveincometaxratecontinuingoperations": 0.001,
    "deferredtaxassetsoperatinglosscarryforwards": 50305000,
    "deferredtaxassetscumulativecapitalizedresearchanddevelopment": 9662000,
    "deferredtaxassetsfederalandstatetaxcredits": 6440000,
    "deferredtaxassetsother": 3647000,
    "deferredtaxassetsgross": 70054000,
    "deferredtaxliabilitiesother": 552000,
    "deferredincometaxliabilities": 552000,
    "deferredtaxassetsvaluationallowance": 69502000,
    "cumulativeoperatinglosscarryforwards": 8100000,
    "operatinglosscarryforwards": 186900000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "incometaxreconciliationtaxcreditsresearch": 848000,
    "taxcreditcarryforwardamount": 6200000,
    "taxcreditcarryforwardsexpirationyear": 2032,
    "percentageoftaxableincomeoffsetbyoperatinglosscarryforwards": 0.8,
    "currentresearchtaxcreditreceivable": 32000,
    "incometaxexaminationyearunderexamination": 2013,
    "deferredtaxassetscapitalizedresearchanddevelopment": 4837000,
    "valuationallowancedeferredtaxassetchangeinamount": 8400000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 31227802,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9703704,
    "milestonepaymentstobepaid": 300000,
    "royaltytermsandconditions": "first commercial sale of the product in that country and extends until the later of the expiration, unenforceability or invalidation of the last valid claim of any licensed patent or application covering the licensed product in the country or the expiration of 10 years after the first commercial sale of the licensed product in the country, which period is referred to as the royalty term. Upon the expiration of the royalty term for a product in a country",
    "definedcontributionplanemployersmatchingcontributioncompliancewithregulatorycapitalrequirements": 126000
  },
  {
    "date": "2022-12-30",
    "symbol": "TRVI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "TREVI THERAPEUTICS, INC.",
    "entitycentralindexkey": 1563880,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "December 31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "TRVI",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-38886",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "45-0834299",
    "entityaddressaddressline1": "195 Church Street",
    "entityaddressaddressline2": "16th Floor",
    "entityaddresscityortown": "New Haven",
    "entityaddressstateorprovince": "Connecticut",
    "entityaddresspostalzipcode": 6510,
    "cityareacode": 203,
    "localphonenumber": "304-2499",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Hartford, Connecticut",
    "cashandcashequivalentsatcarryingvalue": 12589000,
    "marketablesecuritiescurrent": 107921000,
    "prepaidexpensecurrent": 795000,
    "otherassetscurrent": 1311000,
    "assetscurrent": 122616000,
    "otherassetsnoncurrent": 205000,
    "operatingleaserightofuseasset": 24000,
    "propertyplantandequipmentnet": 170000,
    "assets": 123015000,
    "accountspayablecurrent": 2857000,
    "accruedliabilitiescurrent": 3518000,
    "loanspayablecurrent": 7000000,
    "operatingleaseliabilitycurrent": 25000,
    "liabilitiescurrent": 13400000,
    "longtermloanspayable": 2151000,
    "operatingleaseliabilitynoncurrent": 2000,
    "otherliabilitiesnoncurrent": 3000,
    "liabilities": 15556000,
    "commonstockvalue": 60000,
    "additionalpaidincapital": 317590000,
    "accumulatedothercomprehensiveincomelossnetoftax": -122000,
    "retainedearningsaccumulateddeficit": -210069000,
    "stockholdersequity": -210069000,
    "liabilitiesandstockholdersequity": 123015000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 19834000,
    "generalandadministrativeexpense": 10073000,
    "operatingexpenses": 29907000,
    "operatingincomeloss": -29907000,
    "embeddedderivativegainlossonembeddedderivativenet": -147000,
    "othernonoperatingincomeexpense": 289000,
    "interestincomeexpensenonoperatingnet": 1740000,
    "interestexpense": 1163000,
    "nonoperatingincomeexpense": 719000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -29188000,
    "incometaxexpensebenefit": -36000,
    "netincomeloss": -29152000,
    "earningspersharebasic": -0.45,
    "earningspersharediluted": -0.45,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -122000,
    "comprehensiveincomenetoftax": -29274000,
    "sharesoutstanding": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2327000,
    "stockissuedduringperiodvaluestockoptionsexercised": 139000,
    "stockissuedduringperiodsharesstockoptionsexercised": 51005,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 56000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 54457,
    "stockissuedduringperiodvaluenewissues": 105395000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluestockwarrantexercised": 11783000,
    "stockissuedduringperiodsharestockwarrantexercised": "null",
    "availableforsaledebtsecuritiesgrossunrealizedloss": 122000,
    "depreciation": 43000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 829000,
    "changesinfairvalueoftermloanderivativeliability": 147000,
    "amortizationoffinancingcostsanddiscounts": 520000,
    "sharebasedcompensation": 815000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 601000,
    "increasedecreaseinaccountspayable": 9000,
    "increasedecreaseinaccruedliabilities": -639000,
    "netcashprovidedbyusedinoperatingactivities": -28175000,
    "proceedsfrommaturitiesofavailableforsalemarketablesecurities": 19001000,
    "paymentstoacquiremarketablesecurities": 126215000,
    "paymentstoacquirepropertyplantandequipment": 159000,
    "netcashprovidedbyusedininvestingactivities": -107373000,
    "repaymentsoflongtermdebt": 5833000,
    "paymentsoffinancingcosts": 21000,
    "proceedsfromissuanceofprivateplacement": 105410000,
    "proceedsfromwarrantexercises": 11782000,
    "proceedsfromstockoptionsexercised": 139000,
    "proceedsfromstockplans": 56000,
    "paymentsofstockissuancecosts": 800000,
    "netcashprovidedbyusedinfinancingactivities": 111307000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -24241000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 12589000,
    "interestpaidnet": 594000,
    "offeringcostsincludedinaccruedexpenses": 15000,
    "cashcashequivalentsandmarketablesecurities": 120500000,
    "propertyplantandequipmentusefullife": "five years",
    "numberofreportablesegments": 1,
    "numberofoperatingsegments": 1,
    "availableforsaledebtsecuritiesamortizedcostbasis": 108043000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 87000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 209000,
    "availableforsalesecuritiesdebtsecurities": 107921000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearamortizedcost": 69527000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsamortizedcost": 38516000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 69367000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughfiveyearsfairvalue": 38554000,
    "cashandcashequivalentsfairvaluedisclosure": 11589000,
    "investmentsfairvaluedisclosure": 30739000,
    "assetsfairvaluedisclosure": 119510000,
    "fairvalueliabilitiesmeasuredonrecurringbasischangeinunrealizedgainloss": 147000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": 261000,
    "lesseeoperatingleasetermofcontract": 24,
    "operatingleasesrentexpensenet": 123000,
    "operatingleaseweightedaveragediscountratepercent": 0.13,
    "lesseeoperatingleaseremainingleaseterm": "one year",
    "operatingleasepayments": 130000,
    "operatingleaseliability": 27000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 25000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1000,
    "lesseeoperatingleaseliabilitypaymentsdue": 28000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1000,
    "propertyplantandequipmentgross": 395000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 225000,
    "accruedemployeebenefitscurrent": 1508000,
    "accruedresearchanddevelopmentliabilities": 1130000,
    "otheraccruedliabilitiescurrent": 498000,
    "accruedconsultingandprofessionalfees": 382000,
    "debtinstrumentfaceamount": 8199999.999999999,
    "longtermdebtpercentagebearingvariableinterestrate": 0.0536,
    "debtinstrumentmaturitydate": "February 1, 2024",
    "debtinstrumentfeeamount": 1200000,
    "deferredfinancecostsnet": 21000,
    "amortizationofdeferredcharges": 68000,
    "unamortizeddeferredcharges": 29000,
    "accretionexpense": 9000,
    "loandiscountsonfinancingcosts": 3000,
    "accrualoffinalpaymentfee": 383000,
    "debtinstrumentfeeamountaccrued": 1040000,
    "contingentinterestrateincrease": 0.02,
    "amortizationofdebtdiscountpremium": 60000,
    "termloandiscountsinterest": 24000,
    "derivativeliabilitymeasurementinput": 0.12,
    "loanspayable": 9151000,
    "interestexpensedebtexcludingamortization": 643000,
    "amortizationoffinancingcosts": 137000,
    "maximumaggregateofferingpriceofcommonstockwhichmayissueandsaleunderagreement": 62000000,
    "proceedsfromissuanceofcommonstock": 11000000,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexercised": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 1.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": 5.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 803976,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 701232,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoutstandingnumberofsharestilldate": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "two years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Options granted under the 2019 Plan and the 2012 Plan have a maximum term of ten years. Options granted to employees, officers and non-employees generally vest over four years based on varying vesting schedules that primarily include: 25% vesting on the first anniversary date of grant and the balance ratably over the next 36 months or vesting in equal monthly or quarterly installments over four years.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 0.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 2900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 33000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 2900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 53513,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 43921,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.11,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.59,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 5.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 1.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedweightedaveragecontractualterm": 8.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 1672000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 65000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedaggregateintrinsicvalue": 1607000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.024,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.033,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.9,
    "currentstateandlocaltaxexpensebenefit": -36000,
    "currentfederalstateandlocaltaxexpensebenefit": -36000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.057999999999999996,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.287,
    "effectiveincometaxratereconciliationrefundabletaxcredit": 0.001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.025,
    "effectiveincometaxratereconciliationpermanentadjustments": -0.006,
    "effectiveincometaxratecontinuingoperations": 0.001,
    "deferredtaxassetsoperatinglosscarryforwards": 48030000,
    "deferredtaxassetsfederalandstatetaxcredits": 5569000,
    "deferredtaxassetscapitalizedresearchanddevelopment": 4825000,
    "deferredtaxassetsother": 2868000,
    "deferredtaxassetsgross": 61292000,
    "deferredtaxliabilitiesother": 220000,
    "deferredincometaxliabilities": 220000,
    "deferredtaxassetsvaluationallowance": 61072000,
    "cumulativeoperatinglosscarryforwards": 8700000,
    "operatinglosscarryforwards": 178400000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "incometaxreconciliationtaxcreditsresearch": 118000,
    "taxcreditcarryforwardamount": 5400000,
    "taxcreditcarryforwardsexpirationyear": 2042,
    "percentageoftaxableincomeoffsetbyoperatinglosscarryforwards": 0.8,
    "currentresearchtaxcreditreceivable": 36000,
    "incometaxexaminationyearunderexamination": 2021,
    "valuationallowancedeferredtaxassetchangeinamount": 8400000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": "null",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "milestonepaymentstobepaid": 800000,
    "royaltytermsandconditions": "first commercial sale of the product in that country and extends until the later of the expiration, unenforceability or invalidation of the last valid claim of any licensed patent or application covering the licensed product in the country or the expiration of 10 years after the first commercial sale of the licensed product in the country, which period is referred to as the royalty term. Upon the expiration of the royalty term for a product in a country",
    "definedcontributionplanemployersmatchingcontributioncompliancewithregulatorycapitalrequirements": 90000
  },
  {
    "date": "2021-12-30",
    "symbol": "TRVI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "TREVI THERAPEUTICS, INC.",
    "entitycentralindexkey": 1563880,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "TRVI",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-38886",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "45-0834299",
    "entityaddressaddressline1": "195 Church Street",
    "entityaddressaddressline2": "14th Floor",
    "entityaddresscityortown": "New Haven",
    "entityaddressstateorprovince": "Connecticut",
    "entityaddresspostalzipcode": 6510,
    "cityareacode": 203,
    "localphonenumber": "304-2499",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young, LLP",
    "auditorlocation": "Hartford, Connecticut",
    "cashandcashequivalentsatcarryingvalue": 36830000,
    "prepaidexpensecurrent": 886000,
    "otherassetscurrent": 241000,
    "assetscurrent": 37957000,
    "otherassetsnoncurrent": 334000,
    "operatingleaserightofuseasset": 131000,
    "propertyplantandequipmentnet": 53000,
    "assets": 38475000,
    "accountspayablecurrent": 2849000,
    "accruedliabilitiescurrent": 3808000,
    "loanspayablecurrent": 5833000,
    "derivativefairvalueofderivativeliabilitycurrent": 114000,
    "operatingleaseliabilitycurrent": 120000,
    "liabilitiescurrent": 12724000,
    "longtermloanspayable": 8652000,
    "derivativefairvalueofderivativeliability": 114000,
    "operatingleaseliabilitynoncurrent": 24000,
    "liabilities": 21400000,
    "commonstockvalue": 29000,
    "additionalpaidincapital": 197963000,
    "retainedearningsaccumulateddeficit": -180917000,
    "stockholdersequity": -180917000,
    "liabilitiesandstockholdersequity": 38475000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 22984000,
    "generalandadministrativeexpense": 9492000,
    "operatingexpenses": 32476000,
    "operatingincomeloss": -32476000,
    "embeddedderivativegainlossonembeddedderivativenet": 82000,
    "othernonoperatingexpense": 375000,
    "interestincomeexpensenonoperatingnet": 10000,
    "interestexpense": 1202000,
    "nonoperatingincomeexpense": -1485000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -33961000,
    "incometaxexpensebenefit": -21000,
    "netincomeloss": -33940000,
    "earningspersharebasicanddiluted": -1.49,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2543000,
    "stockissuedduringperiodsharesstockoptionsexercised": "null",
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 39000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 42290,
    "stockissuedduringperiodvaluenewissues": 7095000,
    "stockissuedduringperiodsharesnewissues": "null",
    "issuanceofcommonstockasconsiderationtopurchasevalue": 375000,
    "issuanceofcommonstockasconsiderationtopurchaseshares": 170088,
    "stockandwarrantsissuedduringperiodvaluenewissues": 13678000,
    "stockandwarrantsissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluestockwarrantexercised": 3000,
    "stockissuedduringperiodsharestockwarrantexercised": "null",
    "depreciation": 50000,
    "changesinfairvalueoftermloanderivativeliability": -82000,
    "amortizationoffinancingcostsanddiscounts": 599000,
    "expenserelatedtoothertransactions": 375000,
    "sharebasedcompensation": 743000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -342000,
    "increasedecreaseinaccountspayable": 831000,
    "increasedecreaseinaccruedliabilities": 336000,
    "netcashprovidedbyusedinoperatingactivities": -28946000,
    "paymentsoffinancingcosts": 68000,
    "proceedsfromatmarketsalesnetofcommissions": 7505000,
    "proceedsfromstockplans": 39000,
    "proceedsfromwarrantexercises": 3000,
    "proceedsfromissuanceofprivateplacement": 13678000,
    "paymentsofstockissuancecosts": 800000,
    "netcashprovidedbyusedinfinancingactivities": 20775000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -8171000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 36830000,
    "interestpaidnet": 603000,
    "incometaxcreditsexchangedforcash": 18000,
    "offeringcostsincludedinaccruedexpenses": 41000,
    "cashandcashequivalentsfairvaluedisclosure": 35835000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 114000,
    "fairvalueliabilitiesmeasuredonrecurringbasischangeinunrealizedgainloss": -82000,
    "propertyplantandequipmentusefullife": "five years",
    "numberofreportablesegments": 1,
    "numberofoperatingsegments": 1,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "operatingleasesrentexpensenet": 120000,
    "operatingleaseweightedaveragediscountratepercent": 0.13,
    "lesseeoperatingleaseremainingleaseterm": 1.2,
    "operatingleasepayments": 139000,
    "operatingleaseliability": 144000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 131000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 24000,
    "lesseeoperatingleaseliabilitypaymentsdue": 155000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 11000,
    "propertyplantandequipmentgross": 235000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 182000,
    "accruedresearchanddevelopmentliabilities": 2303000,
    "accruedemployeebenefitscurrent": 1250000,
    "accruedconsultingandprofessionalfees": 176000,
    "otheraccruedliabilitiescurrent": 79000,
    "debtinstrumentfaceamount": 14000000,
    "longtermdebtpercentagebearingvariableinterestrate": 0.0425,
    "debtinstrumentmaturitydate": "February 1, 2024",
    "debtinstrumentfeeamount": 1200000,
    "amortizationofdeferredcharges": 40000,
    "unamortizeddeferredcharges": 76000,
    "accretionexpense": 11000,
    "unamortizedloandiscountsonfinancingcosts": 12000,
    "debtinstrumentfeeamountaccrued": 657000,
    "contingentinterestrateincrease": 0.02,
    "loanspayablefairvaluedisclosure": 114000,
    "financialliabilitiesfairvaluedisclosure": 82000,
    "amortizationofdebtdiscountpremium": 74000,
    "termloandiscountsinterest": 84000,
    "derivativeliabilitymeasurementinput": 0.12,
    "loandiscountsonfinancingcosts": 12000,
    "loanspayable": 14485000,
    "interestexpensedebtexcludingamortization": 603000,
    "accrualoffinalandamendmentfees": 474000,
    "amortizationoffinancingcosts": 125000,
    "proceedsfromissuanceofcommonstock": 11000000,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.94,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 518918,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 470631,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoutstandingnumberofsharestilldate": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardannualincreaseinnumberofsharesminimum": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardannualincreaseminimumpercentageofoutstandingstock": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "two years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Options granted under the 2019 Plan and the 2012 Plan have a maximum term of ten years. Options granted to employees, officers and non-employees generally vest over four years based on varying vesting schedules that primarily include: 25% vesting on the first anniversary date of grant and the balance ratably over the next 36 months or vesting in equal monthly or quarterly installments over four years.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 2400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 3800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 445116,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 272764,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.3,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 5.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 3.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedweightedaveragecontractualterm": "P8Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9400000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y6M",
    "currentstateandlocaltaxexpensebenefit": -21000,
    "currentfederalstateandlocaltaxexpensebenefit": -21000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.06,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.29100000000000004,
    "effectiveincometaxratereconciliationrefundabletaxcredit": 0.001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.021,
    "effectiveincometaxratecontinuingoperations": 0.001,
    "deferredtaxassetsoperatinglosscarryforwards": 45693000,
    "deferredtaxassetsfederalandstatetaxcredits": 4801000,
    "deferredtaxassetsother": 2237000,
    "deferredtaxassetsgross": 52731000,
    "deferredtaxliabilitiesother": 35000,
    "deferredincometaxliabilities": 35000,
    "deferredtaxassetsvaluationallowance": 52696000,
    "cumulativeoperatinglosscarryforwards": 32100000,
    "operatinglosscarryforwards": 169700000,
    "operatinglosscarryforwardslimitationsonuse": "Due to the Series A preferred stock financing in December 2012 and the shares issued in connection with the Company’s IPO in May 2019, the Company was subject to an “ownership change” under the Code Section 382.  As a result, the Company’s ability to utilize approximately $91.3 million of its NOL carryforwards and approximately $3.0 million of research tax credits is limited.",
    "limitationsonuseoperatinglosscarryforwards": 91300000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "incometaxreconciliationtaxcreditsresearch": 149000,
    "taxcreditcarryforwardamount": 4600000,
    "taxcreditcarryforwardsexpirationyear": 2041,
    "percentageoftaxableincomeoffsetbyoperatinglosscarryforwards": 0.8,
    "limitationsonusetaxcreditsresearch": 3000000,
    "currentresearchtaxcreditreceivable": 21000,
    "incometaxexaminationyearunderexamination": 2020,
    "valuationallowancedeferredtaxassetchangeinamount": 9900000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "milestonepaymentstobepaid": 800000,
    "royaltytermsandconditions": "first commercial sale of the product in that country and extends until the later of the expiration, unenforceability or invalidation of the last valid claim of any licensed patent or application covering the licensed product in the country or the expiration of 10 years after the first commercial sale of the licensed product in the country, which period is referred to as the royalty term. Upon the expiration of the royalty term for a product in a country,",
    "definedcontributionplanemployersmatchingcontributioncompliancewithregulatorycapitalrequirements": 96000
  },
  {
    "date": "2020-12-30",
    "symbol": "TRVI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "TREVI THERAPEUTICS, INC.",
    "entitycentralindexkey": 1563880,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "TRVI",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38886",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "45-0834299",
    "entityaddressaddressline1": "195 Church Street",
    "entityaddressaddressline2": "14th Floor",
    "entityaddresscityortown": "New Haven",
    "entityaddressstateorprovince": "CT",
    "entityaddresspostalzipcode": 6510,
    "cityareacode": 203,
    "localphonenumber": "304-2499",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "cashandcashequivalentsatcarryingvalue": 45001000,
    "taxcreditandotherreceivables": 265000,
    "prepaidexpensecurrent": 1003000,
    "assetscurrent": 46269000,
    "deferredofferingcostsnoncurrent": 284000,
    "operatingleaserightofuseasset": 227000,
    "securitydepositsandothernoncurrentassets": 248000,
    "propertyplantandequipmentnet": 103000,
    "assets": 47131000,
    "accountspayablecurrent": 2016000,
    "accruedliabilitiescurrent": 3426000,
    "operatingleaseliabilitycurrent": 113000,
    "liabilitiescurrent": 5555000,
    "longtermloanspayable": 13954000,
    "derivativefairvalueofderivativeliability": 196000,
    "operatingleaseliabilitynoncurrent": 144000,
    "commonstockvalue": 19000,
    "additionalpaidincapital": 174240000,
    "retainedearningsaccumulateddeficit": -146977000,
    "stockholdersequity": -146977000,
    "liabilitiesandstockholdersequity": 47131000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 18546786,
    "commonstocksharesoutstanding": 18546786,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "researchanddevelopmentexpense": 22328000,
    "generalandadministrativeexpense": 10161000,
    "operatingexpenses": 32489000,
    "operatingincomeloss": -32489000,
    "changeinfairvalueoftermloanderivativeliability": -9000,
    "interestincomeexpensenonoperatingnet": 178000,
    "interestexpense": 456000,
    "nonoperatingincomeexpense": -287000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -32776000,
    "incometaxexpensebenefit": -18000,
    "netincomeloss": -32758000,
    "netincomelossavailabletocommonstockholdersbasic": -32758000,
    "earningspersharebasicanddiluted": -1.81,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 18059011,
    "sharesoutstanding": 18546786,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2417000,
    "stockissuedduringperiodvaluestockoptionsexercised": 34000,
    "stockissuedduringperiodsharesstockoptionsexercised": 18343,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 12000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 5997,
    "stockissuedduringperiodvaluenewissues": 3032000,
    "stockissuedduringperiodsharesnewissues": 687876,
    "depreciation": 47000,
    "changesinfairvalueoftermloanderivativeliability": 9000,
    "amortizationoffinancingcostsanddiscounts": 227000,
    "sharebasedcompensation": 2057000,
    "increasedecreaseintaxcreditandotherreceivables": -293000,
    "increasedecreaseinprepaidexpense": -449000,
    "increasedecreaseinaccountspayable": 417000,
    "increasedecreaseinaccruedliabilities": -101000,
    "netcashprovidedbyusedinoperatingactivities": -29000000,
    "paymentstoacquirepropertyplantandequipment": 32000,
    "netcashprovidedbyusedininvestingactivities": -32000,
    "proceedsfromissuanceoflongtermdebt": 14000000,
    "paymentsoffinancingcosts": 84000,
    "proceedsfromatmarketsalesnetofcommissions": 3135000,
    "proceedsfromstockoptionsexercised": 34000,
    "proceedsfromstockplans": 12000,
    "paymentsofstockissuancecosts": 200000,
    "netcashprovidedbyusedinfinancingactivities": 16720000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -12312000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 45001000,
    "interestpaidnet": 180000,
    "incometaxcreditsexchangedforcash": 18000,
    "offeringcostsincludedinaccruedexpenses": 11000,
    "financialliabilitiesfairvaluedisclosure": 9000,
    "propertyplantandequipmentusefullife": "P5Y",
    "deferredofferingcosts": 284000,
    "stockholdersequityperiodincreasedecrease": -105000,
    "numberofreportablesegments": 1,
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsfairvaluedisclosure": 44095000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 196000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 187000,
    "fairvalueliabilitiesmeasuredonrecurringbasischangeinunrealizedgainloss": 9000,
    "prepaidresearchanddevelopmentexpenses": 333000,
    "prepaidinsurance": 562000,
    "otherprepaidexpensecurrent": 108000,
    "operatingleasesrentexpensenet": 124000,
    "operatingleaseweightedaveragediscountratepercent": 0.13,
    "lesseeoperatingleaseremainingleaseterm": "P2Y3M",
    "operatingleasepayments": 138000,
    "operatingleaseliability": 257000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 138000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 131000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 24000,
    "lesseeoperatingleaseliabilitypaymentsdue": 293000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 36000,
    "propertyplantandequipmentgross": 235000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 132000,
    "accruedresearchanddevelopmentliabilities": 1754000,
    "accruedconsultingandprofessionalfees": 560000,
    "accruedemployeebenefitscurrent": 954000,
    "otheraccruedliabilitiescurrent": 158000,
    "debtinstrumentfaceamount": 14000000,
    "debtinstrumentmaturitydate": "2024-02-01",
    "debtinstrumentfeeamount": 1200000,
    "defaultlongtermdebtdescriptionofviolationoreventofdefault": "If the Company fails to meet certain equity raise requirements under the SVB Loan Agreement, it will be required to deposit unrestricted and unencumbered cash equal to 100% of the principal amount of the SVB Term Loan then outstanding in a cash collateral account with SVB, which can be used by SVB to prepay the SVB Term Loan at any time.",
    "amortizationofdeferredcharges": 9000,
    "unamortizeddeferredcharges": 48000,
    "accretionexpense": 4000,
    "loandiscountsonfinancingcosts": 23000,
    "debtinstrumentfeeamountaccrued": 183000,
    "contingentinterestrateincrease": 0.02,
    "loanspayablefairvaluedisclosure": 196000,
    "amortizationofdebtdiscountpremium": 29000,
    "termloandiscountsinterest": 158000,
    "derivativeliabilitymeasurementinput": 0.12,
    "loanspayable": 13954000,
    "interestexpensedebtexcludingamortization": 231000,
    "amortizationoffinancingcosts": 42000,
    "accrualoffinalandamendmentfees": 183000,
    "commonstockcapitalsharesreservedforfutureissuance": 1578947,
    "shareprice": 1.46,
    "proceedsfromissuanceofcommonstock": 3200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoutstandingnumberofsharestilldate": 1157894,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P2Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2171477,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 764583,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 2200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 81000,
    "allocatedsharebasedcompensationexpense": 5000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 4400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 163463,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 86526,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1009847,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 1161630,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.11,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 7.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 9.18,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 6.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedweightedaveragecontractualterm": "P8Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 185000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 185000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.012,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.815,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y9M18D",
    "convertiblepreferredstocksettlementterms": "In addition, TPG had the right to purchase, on the same terms and conditions as the Series B Initial Closing, including the $1.15 per share purchase price, the lesser of 4,347,826 additional shares of Series B Preferred Stock and the number of shares equal to 25% of the total number of shares it previously purchased for cash under the Series B Purchase",
    "sharesissuedpricepershare": 1.15,
    "accrueddividendsconvertedtocommonshare": 18400000,
    "percentageofpreferredshareholdersremainingoutstanding": 0.6667,
    "fairvalueestimatesofcommonstockdiscountrate": 1.44,
    "fairvalueinputsprobabilityfactor": 0.4,
    "fairvalueinputsestimatedmarketdiscountrate": 0.2,
    "premoneyvaluationcostofequityrate": 0.15,
    "estimatedtimetoinitialpublicofferingdate": "P4M17D",
    "stockholdersequitynotestocksplitconversionratio1": 0.105,
    "percentageconversionofpreferredstockoutstanding": 0.6,
    "currentstateandlocaltaxexpensebenefit": -18000,
    "currentfederalstateandlocaltaxexpensebenefit": -18000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.061,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.291,
    "effectiveincometaxratereconciliationrefundabletaxcredit": 0.001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.02,
    "effectiveincometaxratecontinuingoperations": 0.001,
    "deferredtaxassetsoperatinglosscarryforwards": 37048000,
    "deferredtaxassetsfederalandstatetaxcredits": 4054000,
    "deferredtaxassetsother": 1727000,
    "deferredtaxassetsgross": 42829000,
    "deferredtaxassetsvaluationallowance": 42829000,
    "cumulativeoperatinglosscarryforwards": 30800000,
    "operatinglosscarryforwards": 137600000,
    "operatinglosscarryforwardslimitationsonuse": "Due to the Series A preferred stock financing in December 2012 and the shares issued in connection with the Company’s IPO in May 2019, the Company was subject to an “ownership change” under the Code Section 382.  As a result, the Company’s ability to utilize approximately $91.3 million of its NOL carryforwards and approximately $3.0 million of research tax credits is limited.",
    "limitationsonuseoperatinglosscarryforwards": 91300000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "incometaxreconciliationtaxcreditsresearch": 133000,
    "incometaxreconciliationtaxcreditsresearchbalance": 3900000,
    "taxcreditcarryforwardsexpirationyear": 2039,
    "percentageoftaxableincomeoffsetbyoperatinglosscarryforwards": 0.8,
    "limitationsonusetaxcreditsresearch": 3000000,
    "currentresearchtaxcreditreceivable": 18000,
    "incometaxexaminationyearunderexamination": 2020,
    "valuationallowancedeferredtaxassetchangeinamount": 9500000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2171477,
    "milestonepaymentstobepaid": 1200000,
    "royaltytermsandconditions": "first commercial sale of the product in that country and extends until the later of the expiration, unenforceability or invalidation of the last valid claim of any licensed patent or application covering the licensed product in the country or the expiration of 10 years after the first commercial sale of the licensed product in the country, which period is referred to as the royalty term. Upon the expiration of the royalty term for a product in a country,",
    "definedcontributionplanemployersmatchingcontributioncompliancewithregulatorycapitalrequirements": 68000,
    "costincurredforhealthcareandlifeinsurancebenefits": 407000
  },
  {
    "date": "2019-12-30",
    "symbol": "TRVI",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "TREVI THERAPEUTICS, INC.",
    "entitycentralindexkey": 1563880,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "tradingsymbol": "TRVI",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38886",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "45-0834299",
    "entityaddressaddressline1": "195 Church Street",
    "entityaddressaddressline2": "14th Floor",
    "entityaddresscityortown": "New Haven",
    "entityaddressstateorprovince": "CT",
    "entityaddresspostalzipcode": 6510,
    "cityareacode": 203,
    "localphonenumber": "304-2499",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 57313000,
    "taxcreditandotherreceivables": 558000,
    "prepaidexpensecurrent": 1681000,
    "assetscurrent": 59552000,
    "operatingleaserightofuseasset": 312000,
    "securitydeposit": 19000,
    "propertyplantandequipmentnet": 118000,
    "assets": 60001000,
    "accountspayablecurrent": 1599000,
    "accruedliabilitiescurrent": 3501000,
    "operatingleaseliabilitycurrent": 99000,
    "liabilitiescurrent": 5199000,
    "operatingleaseliabilitynoncurrent": 257000,
    "commonstockvalue": 18000,
    "additionalpaidincapital": 168746000,
    "retainedearningsaccumulateddeficit": -114219000,
    "stockholdersequity": -114219000,
    "liabilitiesandstockholdersequity": 60001000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 17834570,
    "commonstocksharesoutstanding": 17834570,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "researchanddevelopmentexpense": 19339000,
    "generalandadministrativeexpense": 7306000,
    "operatingexpenses": 26645000,
    "operatingincomeloss": -26645000,
    "changeinfairvalueofobligationforloansuccessfee": -215000,
    "interestincomeexpensenonoperatingnet": 792000,
    "nonoperatingincomeexpense": 577000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -26068000,
    "incometaxexpensebenefit": -18000,
    "netincomeloss": -26050000,
    "temporaryequityaccretiontoredemptionvalueadjustment": -1535000,
    "redeemablepreferredstockdividends": 2239000,
    "netincomelossavailabletocommonstockholdersbasic": -26754000,
    "earningspersharebasicanddiluted": -2.28,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 11735781,
    "sharesoutstanding": 17834570,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1127000,
    "stockissuedduringperiodvaluestockoptionsexercised": 38000,
    "stockissuedduringperiodsharesstockoptionsexercised": 14736,
    "issuanceofredeemableconvertiblepreferredstocknetofissuancecost": 11059000,
    "issuanceofredeemableconvertiblepreferredstocknetofissuancecostshares": 6849315,
    "adjustmentstoadditionalpaidincapitaldividendsinexcessofretainedearnings": -2239000,
    "preferredstockdividendsshares": 3792386,
    "accretionamortizationofpremiumdiscountonissuanceofredeemableconvertiblepreferredstock": -24000,
    "accretionofdiscountoninvestorrightsobligation": -201000,
    "adjustmentforexcessoffairvalueliquidationredeemableconvertiblepreferredstock": 1994000,
    "accretionofissuancecostsonredeemableconvertiblepreferredstock": -234000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 127504000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 10381234,
    "stockissuedduringperiodvaluenewissues": 13950000,
    "stockissuedduringperiodsharesnewissues": 1500000,
    "depreciation": 39000,
    "changeinfairvalueloansuccessfee": 215000,
    "sharebasedcompensation": 984000,
    "increasedecreaseinaccountsreceivable": 374000,
    "increasedecreaseinprepaidexpense": 243000,
    "increasedecreaseinaccountspayable": 777000,
    "increasedecreaseinaccruedliabilities": 1416000,
    "netcashprovidedbyusedinoperatingactivities": -23093000,
    "paymentstoacquirepropertyplantandequipment": 9000,
    "netcashprovidedbyusedininvestingactivities": -9000,
    "paymentsforloansuccessfee": 675000,
    "proceedsfromstockoptionsexercised": 38000,
    "proceedsfromissuanceofconvertiblepreferredstock": 9963000,
    "proceedsfromissuanceinitialpublicoffering": 51150000,
    "paymentsofstockissuancecosts": 1213000,
    "proceedsfromissuanceofprivateplacement": 13950000,
    "netcashprovidedbyusedinfinancingactivities": 73213000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 50111000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 57313000,
    "incometaxcreditsexchangedforcash": 124000,
    "dividendaccruedonredeemableconvertiblepreferredstock": 2239000,
    "accretiononredeemableconvertiblepreferredstock": -1535000,
    "shareprice": 1.46,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": 1096000,
    "propertyplantandequipmentusefullife": "P5Y",
    "preferredstockdividendratepercentage": 0.06,
    "numberofreportablesegments": 1,
    "numberofoperatingsegments": 1,
    "operatingleaseliability": 356000,
    "fairvalueliabilitiesmeasuredonrecurringbasischangeinunrealizedgainloss": 215000,
    "prepaidresearchanddevelopmentexpenses": 1113000,
    "prepaidinsurance": 491000,
    "otherprepaidexpensecurrent": 77000,
    "operatingleasesrentexpensenet": 124000,
    "lesseeoperatingleaseexistenceofoptiontoterminate": "true",
    "lesseeoperatingleaseoptiontoterminate": "The Company has the option to terminate the lease after 36 months by providing six months notice along with a payment to the landlord in an amount representing the unamortized cost of tenant improvements plus the unamortized broker’s commission, both of which had been paid by the landlord, and as defined in the agreement",
    "operatingleaseweightedaveragediscountratepercent": 0.13,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y",
    "operatingleasepayments": 125000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 138000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 138000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 131000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 24000,
    "lesseeoperatingleaseliabilitypaymentsdue": 431000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 75000,
    "propertyplantandequipmentgross": 203000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 85000,
    "accruedresearchliabilities": 2084000,
    "accruedprofessionalfeescurrent": 338000,
    "accruedemployeebenefitscurrent": 776000,
    "otheraccruedliabilitiescurrent": 303000,
    "loansuccessfeepercentage": 0.045,
    "discountontermloan": 15000000,
    "noncashcharge": 215000,
    "commonstockcapitalsharesreservedforfutureissuance": 155106,
    "effectivedateofrestatedcertificateofincorporation": "2019-05-09",
    "proceedsfromissuanceofredeemableconvertiblepreferredstock": 2800000,
    "stockissuedduringperiodsharesadditionalissues": 2500000,
    "numberofsharesequaltonumberofsharespreviouslypurchasedforcashpercentage": 0.25,
    "convertiblepreferredstocksettlementterms": "In addition, TPG had the right to purchase, under the same terms and conditions as the Series A Initial Closing, including the $1.00 per share purchase price, the lesser of 2,500,000 additional shares of Series A Preferred Stock (the “Additional Series A Preferred Shares”) and the number of shares of Series A Preferred Stock equal to 25% of the total number of shares of Series A Preferred Stock it previously purchased for cash under the Series A Purchase Agreement.",
    "sharesissuedpricepershare": 1.15,
    "amortizationofstockissuancecosts": 7000,
    "unaccreteddiscount": 5000,
    "preferredstockaccretionofredemptiondiscount": 31000,
    "unaccretedpremium": 22000,
    "accrueddividendsconvertedtocommonshare": 18400000,
    "percentageofpreferredshareholdersremainingoutstanding": 0.6667,
    "fairvalueestimatesofcommonstockdiscountrate": 1.44,
    "fairvalueinputsprobabilityfactor": 0.4,
    "fairvalueinputsestimatedmarketdiscountrate": 0.2,
    "premoneyvaluationcostofequityrate": 0.15,
    "estimatedtimetoinitialpublicofferingdate": "P4M17D",
    "paymentsoffinancingcosts": 379000,
    "accretionoffinancingcosts": 223000,
    "unaccretedfinancingcosts": 164000,
    "fairvalueadjustmentonpreferredstockvalue": 520000,
    "accretionofinvestorrights": 117000,
    "unaccretedinvestorrights": 85000,
    "proceedsfromseriesapreferredstockfinancing": 2000000,
    "stockholdersequitynotestocksplitconversionratio1": 0.105,
    "percentageconversionofpreferredstockoutstanding": 0.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1675226,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Options vest over four years based on varying vesting schedules including: 25% vesting on the first anniversary date of grant and the balance ratably over the next 36 months or vesting in equal monthly or quarterly installments over four years.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 678602,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 688000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 105000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 3900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 59429,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 6359,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 695454,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 979772,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.2,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 8.6,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 3.08,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 8.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedweightedaveragecontractualterm": "P9Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 864000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 771000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunvestedinperiodfairvalue": 93000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.787,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "currentstateandlocaltaxexpensebenefit": -18000,
    "currentfederalstateandlocaltaxexpensebenefit": -18000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.059,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.282,
    "effectiveincometaxratereconciliationrefundabletaxcredit": 0.001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.014,
    "effectiveincometaxratereconciliationleasestandardadoption": -0.001,
    "effectiveincometaxratecontinuingoperations": 0.001,
    "deferredtaxassetsoperatinglosscarryforwards": 28745000,
    "deferredtaxassetsfederalandstatetaxcredits": 3350000,
    "deferredtaxassetsother": 1200000,
    "deferredtaxassetsgross": 33295000,
    "deferredtaxassetsvaluationallowance": 33295000,
    "cumulativeoperatinglosscarryforwards": 23900000,
    "operatinglosscarryforwards": 106800000,
    "operatinglosscarryforwardslimitationsonuse": "Due to the Series A preferred stock financing in December 2012 and the shares issued in connection with the Company’s IPO in May 2019, the Company was subject to an “ownership change” under the Code Section 382.  As a result, the Company’s ability to utilize approximately $91.3 million of its NOL carryforwards and approximately $3.0 million of research tax credits is limited.",
    "limitationsonuseoperatinglosscarryforwards": 91300000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "incometaxreconciliationtaxcreditsresearch": 82000,
    "incometaxreconciliationtaxcreditsresearchbalance": 3200000,
    "taxcreditcarryforwardsexpirationyear": 2039,
    "percentageoftaxableincomeoffsetbyoperatinglosscarryforwards": 0.8,
    "limitationsonusetaxcreditsresearch": 3000000,
    "incometaxreceivable": 18000,
    "incometaxexaminationyearunderexamination": 2019,
    "valuationallowancedeferredtaxassetchangeinamount": 7400000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1675226,
    "paymentforupfrontlicensefee": 119000,
    "milestonepaymentliability": 1188000,
    "royaltytermsandconditions": "first commercial sale of the product in that country and extends until the later of the expiration, unenforceability or invalidation of the last valid claim of any licensed patent or application covering the licensed product in the country or the expiration of 10 years after the first commercial sale of the licensed product in the country, which period is referred to as the royalty term. Upon the expiration of the royalty term for a product in a country,",
    "definedcontributionplanemployersmatchingcontributioncompliancewithregulatorycapitalrequirements": 111000,
    "costincurredforhealthcareandlifeinsurancebenefits": 289000
  }
]